Prescription monitoring programs and emergency department visits involving opioids, 2004-2011.
暂无分享,去创建一个
[1] Daniel W Webster,et al. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use. , 2015, JAMA internal medicine.
[2] Zachary F. Meisel,et al. How, why, and for whom do emergency medicine providers use prescription drug monitoring programs? , 2015, Pain medicine.
[3] Chris Ringwalt,et al. The Effects of North Carolina’s Prescription Drug Monitoring Program on the Prescribing Behaviors of the State’s Providers , 2015, The Journal of Primary Prevention.
[4] Lainie Rutkow,et al. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. , 2015, Health affairs.
[5] Tamara M Haegerich,et al. What we know, and don't know, about the impact of state policy and systems-level interventions on prescription drug overdose. , 2014, Drug and alcohol dependence.
[6] Pradeep Rajan,et al. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. , 2014, Pain medicine.
[7] Li Hui Chen,et al. Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011. , 2014, NCHS data brief.
[8] L. Paulozzi,et al. Decline in Drug Overdose Deaths After State Policy Changes — Florida, 2010–2012 , 2014, MMWR. Morbidity and mortality weekly report.
[9] Miguel Marino,et al. Who uses a prescription drug monitoring program and how? Insights from a statewide survey of Oregon clinicians. , 2014, The journal of pain : official journal of the American Pain Society.
[10] Christopher M. Jones,et al. Risk of Adverse Health Outcomes with Increasing Duration and Regularity of Opioid Therapy , 2014, The Journal of the American Board of Family Medicine.
[11] Barbara H. Lang,et al. Prescription Drug Monitoring and Dispensing of Prescription Opioids , 2014, Public health reports.
[12] W. K. Kennedy,et al. Benzodiazepines , 2014, Journal of pharmacy practice.
[13] Franklin D. Friedman,et al. Clinician impression versus prescription drug monitoring program criteria in the assessment of drug-seeking behavior in the emergency department. , 2013, Annals of emergency medicine.
[14] Lewis S. Nelson,et al. Prescribing Practices, Knowledge, and Use of Prescription Drug Monitoring Programs (PDMP) by a National Sample of Medical Toxicologists, 2012 , 2012, Journal of Medical Toxicology.
[15] J. Qian,et al. Influence of prescription monitoring programs on analgesic utilization by an insured retiree population , 2012, Pharmacoepidemiology and drug safety.
[16] P. Friedmann,et al. How does use of a prescription monitoring program change medical practice? , 2012, Pain medicine.
[17] A. Kolbasovsky,et al. Impact of a managed controlled-opioid prescription monitoring program on care coordination. , 2012, The American journal of managed care.
[18] M. Knox,et al. Influencing controlled substance prescribing: attending and resident physician use of a state prescription monitoring program. , 2012, Pain medicine.
[19] S. Schnoll,et al. Do prescription monitoring programs impact state trends in opioid abuse/misuse? , 2012, Pain medicine.
[20] Wayne Wakeland,et al. An analysis of the root causes for opioid-related overdose deaths in the United States. , 2011, Pain medicine.
[21] Leonard J Paulozzi,et al. Prescription drug monitoring programs and death rates from drug overdose. , 2011, Pain medicine.
[22] T. Gomes,et al. Opioid dose and drug-related mortality in patients with nonmalignant pain. , 2011, Archives of internal medicine.
[23] Dieter Henkel,et al. Unemployment and substance use: a review of the literature (1990-2010). , 2011, Current drug abuse reviews.
[24] C. Marco,et al. A statewide prescription monitoring program affects emergency department prescribing behaviors. , 2010, Annals of emergency medicine.
[25] B. Psaty,et al. Opioid Prescriptions for Chronic Pain and Overdose , 2010, Annals of Internal Medicine.
[26] D. Juurlink,et al. Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone , 2009, Canadian Medical Association Journal.
[27] Douglas J. Lorenz,et al. Epidemiological Trends in Abuse and Misuse of Prescription Opioids , 2009, Journal of addictive diseases.
[28] Adam J. Atherly,et al. Prescription Opioid Usage and Abuse Relationships: An Evaluation of State Prescription Drug Monitoring Program Efficacy , 2009, Substance abuse : research and treatment.
[29] O. Blin,et al. Impact of a prescription monitoring program on doctor‐shopping for high dosage buprenorphine , 2009, Pharmacoepidemiology and drug safety.
[30] Benjamin French,et al. Analysis of longitudinal data to evaluate a policy change , 2008, Statistics in medicine.
[31] R. Mattick,et al. The ratio of non-fatal to fatal heroin overdose. , 2003, Addiction.
[32] J. Neale. A response to Darke et al., 'The ratio of non-fatal to fatal heroin overdose'. , 2003, Addiction.
[33] M. Valenstein,et al. Association Between Opioid Prescribing Patterns and Opioid Overdose-Related Deaths , 2012 .
[34] E. Kilbourne,et al. OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION Original Research Article A History of Being Prescribed Controlled Substances and Risk of Drug Overdose Death , 2012 .
[35] L. Paulozzi,et al. Emergency department visits involving nonmedical use of selected prescription drugs - United States, 2004-2008. , 2010, MMWR. Morbidity and mortality weekly report.
[36] Patrick M O'Malley,et al. Substance use among adults 35 years of age: prevalence, adulthood predictors, and impact of adolescent substance use. , 2004, American journal of public health.